SeaSpine Inc.

99 articles about SeaSpine Inc.

• Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results

  3/6/2023

  The merger of Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023.

• Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company

  1/4/2023

  Orthofix Medical Inc. and SeaSpine Holdings Corporation announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders.

• SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System

  12/27/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the placement of its 100th 7D FLASH™ Navigation System globally.

• Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

  11/18/2022

  Orthofix and SeaSpine announced that John Bostjancic will serve as Chief Financial Officer for the new combined company, effective upon the completion of their pending merger.

• SeaSpine to Present at the Stifel 2022 Healthcare Conference

  11/2/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference.

• SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022

  11/1/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the third quarter of 2022.

• SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System

  10/31/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the full commercial launch of the Mariner® MIS Wayfinder System.

• SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022

  10/24/2022

  SeaSpine Holdings Corporation today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022.

• SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance

  10/11/2022

  SeaSpine Holdings Corporation announced preliminary financial results for the third quarter of 2022.

• Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company

  10/11/2022

  Orthofix and SeaSpine announced they have entered into a definitive agreement to combine in an all-stock merger of equals.

• SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit FacilityProvides for up to an additional $10 million of liquidity

  7/19/2022

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has amended its credit facility with Wells Fargo Bank, N.A.

• SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families

  5/2/2022

  SeaSpine Holdings Corporation announced the full commercial launch of OsteoTorrent and OsteoTorrent C, both of which are new Accell DBM Putties packaged and sterilized in a dry state and designed to further improve osteoinductive potential and shelf-life, while allowing surgeons to reconstitute with saline, blood or bone marrow aspirate.

• SeaSpine® Announces Full Commercial Launch of Explorer® TO Expandable Interbody System

  4/28/2022

  SeaSpine Holdings Corporation announced the full commercial launch of the Explorer® TO Expandable Interbody System.

• SeaSpine® Announces 50,000th NanoMetalene® Implantation

  3/24/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the implantation of the 50,000th NanoMetalene® interbody device.

• SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial ResultsProvides 2022 Revenue Guidance

  3/11/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months and full-year ended December 31, 2021.

• SeaSpine® Announces New Senior Leadership Team Appointments

  3/7/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and Shaeffer Bannigan to Vice President, Product Development, Spinal Implants.

• SeaSpine® Announces Full Commercial Launch of NorthStar™ Facet Fusion and Limited Commercial Launch of FLASH™ Navigation Lumbar Facet Fusion

  3/1/2022

  SeaSpine Holdings Corporation announced the full commercial launch of NorthStar™ Cervical Facet Fusion and the limited commercial launch of FLASH™ Navigation Lumbar Facet Fusion, the latest orthobiologics solutions tailored to specific procedural needs.

• SeaSpine to Host Virtual Analyst and Investor Day on March 11, 2022

  2/24/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it will release fourth quarter and full year 2021 financial results on Friday, March 11, 2022.

• SeaSpine Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Including Record Fourth Quarter 2021 Revenue

  1/10/2022

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced preliminary financial results for the fourth quarter and full year 2021.

• SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors

  12/14/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has appointed Angela Steinway to its Board of Directors, effective December 14, 2021.